Triall logo

Triall (TRL)

Status
ICO
IDO

Triall’s mission is to accelerate the introduction of safe and affordable vaccines and therapeutics into society by streamlining clinical trials.

Triall White Paper Whitepaper

Important By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.

Interest lvl
Medium
Learn more about our rating
User Rating
Highest
4.3/5 6 votes
Claim your project
Ticker
TRL
Type
Utility-token
Token standard
ERC20
FoundedNetherlands
Registration countryNetherlands
Registration year2018
Office addressBisonspoor 3002 – C701 (Copenhagen Tower), 3605 LT Maarssen, The Netherlands
Launchpads

What is Triall

Triall is laying the groundwork for tomorrow’s digital playing field in clinical trials. We bring Web 3.0 to medical research by developing a digital ecosystem of blockchain-integrated software solutions. Our blockchain infrastructure makes medical data tamper-resistant. It also enables secure and efficient connections between the many isolated systems and parties involved in clinical research. Our mission is to accelerate the introduction of safe and affordable vaccines and therapeutics into society by streamlining clinical trials. We bring Web 3.0 to medical research, by realizing a digital ecosystem for clinical trials. What are the unique benefits of the Triall ecosystem?
    • System Integration & Interoperability
Blockchain-agnostic, decentralized identity and access management. Secure connections and exchanges between isolated clinical trial systems and their users.
    • Efficiency & Operational Excellence
Integrated clinical trial metrics. Automation and assertion of clinical trial workflows through AI and smart contracts.
    • Data integrity & Auditability
Blockchain-secured, tamper-resistant audit trails of clinical documents and data.
  • Availability & Ease of Use
Ecosystem utilities available from anywhere. On any device. Through a secured cloud-based environment.

Token Sale Dates

IDO

Start date: Sep 28, 2021
End date: Sep 28, 2021

IDO

Start date: Sep 28, 2021
End date: Sep 28, 2021

Token Allocation

Total Token Supply 175,000,000 TRL
Total Tokens for Sale 18,250,000 TRL

Funding Details

Hard Cap 2,993,750 USD

Funds allocation


Liquidity, long-term operations & development - 8%
18% - Pre-sale
24% - Treasury
10% - Triall Community Fund
12,5% - Existing investors
8% - Advisors
10% - Founding team
9,5% - Growth, acquisition & marketing

Token Price and Payment Options

Token price USD 1 TRL = 0,2 USD
Accepted Currencies USDT

Project team

Hadil Es-Sbai, MSc
Hadil Es-Sbai, MSc
President | CEO
Hadil Es-Sbai, MSc linkedin-team
Niels Klomp, MSc
Niels Klomp, MSc
CTO
Niels Klomp, MSc linkedin-team
Dr. Linda van de Burgwal
Dr. Linda van de Burgwal
CFO
Dr. Linda van de Burgwal linkedin-team
Rob Posthumus, LL.M.
Rob Posthumus, LL.M.
General Counsel
Rob Posthumus, LL.M. linkedin-team
Raymond van der Waal, MSc
Raymond van der Waal, MSc
Head of Marketing
Raymond van der Waal, MSc linkedin-team
Dr. Joost Flach
Dr. Joost Flach
Head of Clinical Affairs
Dr. Joost Flach linkedin-team
Mark van der Waal, MSc
Mark van der Waal, MSc
Head of Product
Mark van der Waal, MSc linkedin-team

Advisors

Sina Djali
Sina Djali
Head of Integrated Data Analytics Janssen Pharmaceuticals (J&J)
Sina Djali linkedin-team
Danielle Bradbury
Danielle Bradbury
VP Quality Assurance Galera Therapeutics
Danielle Bradbury linkedin-team
Prof. Niels Chavannes, MD, PhD
Prof. Niels Chavannes, MD, PhD
Head of Research, Public Health & Primary Care Leiden University Medical Center
Prof. Niels Chavannes, MD, PhD linkedin-team
Cari Jacobs Blom
Cari Jacobs Blom
Director Quality & Compliance CR2O
Cari Jacobs Blom linkedin-team
Prof. Sjaak Bloem, PhD
Prof. Sjaak Bloem, PhD
Associate Director Behavioral Science Janssen Pharmaceuticals (J&J)
Prof. Sjaak Bloem, PhD linkedin-team
Allan Bukuya
Allan Bukuya
COO TrialDocs International
Allan Bukuya linkedin-team
Nick van den Bulk
Nick van den Bulk
Head Clinical Operations CR2O
Nick van den Bulk linkedin-team
Prof. Eric Claassen, PhD
Prof. Eric Claassen, PhD
Sequential Biotech Entrepreneur & Angel Investor Multiple ventures
Prof. Eric Claassen, PhD linkedin-team

Social media

Industries

One Response

  • dSeptember 27, 2021 at 12:11 am

    i like this project nice that i have invet in this project

    Reply
  • Leave a Reply

    Your email address will not be published. Required fields are marked *

    listing on exchanges

    One Response

  • dSeptember 27, 2021 at 12:11 am

    i like this project nice that i have invet in this project

    Reply
  • Leave a Reply

    Your email address will not be published. Required fields are marked *

    Sponsored Crypto Projects

    KYMAi (KYMAI) logo
    KYMAi (KYMAI) Sponsored
    KYMAi (KYMAI)
    Low
    ICO
    NOCtura (NOC) logo
    NOCtura (NOC) Sponsored
    NOCtura (NOC)
    Low
    ICO
    Zama (ZAMA) logo
    Zama (ZAMA)
    High
    ICO
    IEO

    Newly Published